LIMK2 and breast cancer: We found that single knockdown of LIMK1 or LIMK2 triggered a strong decrease (about 80%) in matrix degradation without affecting MT1-MMP levels or expression of the other LIMK isoform in MDA-MB-231 cells and BT-549 breast cancer cells.